These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4981706)

  • 61. Vibrio mutants of Rhodospirillum rubrum.
    Newton JW
    Biochim Biophys Acta; 1971 Aug; 244(2):478-80. PubMed ID: 5125626
    [No Abstract]   [Full Text] [Related]  

  • 62. [Mechanisms of action of enduracidin. 2. Inhibition of cell wall synthesis in Staphylococcus aureus].
    Takeuchi Y; Tsuchiya K
    Nihon Saikingaku Zasshi; 1968 Jul; 23(7):449-56. PubMed ID: 5749775
    [No Abstract]   [Full Text] [Related]  

  • 63. [Resistance of the tuberculosis bacillus to ethionamide, cycloserine, and viomycin noting coexistant resistance to streptomycin, isonicotinic acid, and para-aminosalicylic acid].
    Rudnicka M; Suszko K
    Med Dosw; 1966; 33():291-302. PubMed ID: 4287506
    [No Abstract]   [Full Text] [Related]  

  • 64. The configuration of D-alanyl-D-cycloserine confirmed.
    Levine CS; Stammer CH
    J Org Chem; 1972 Jan; 37(1):148-50. PubMed ID: 5007353
    [No Abstract]   [Full Text] [Related]  

  • 65. A screening method for cell wall inhibitors using a D-cycloserine hypersensitive mutant.
    Kamogashira T; Takegata S
    J Antibiot (Tokyo); 1988 Jun; 41(6):803-6. PubMed ID: 3403376
    [No Abstract]   [Full Text] [Related]  

  • 66. Metabolomics Reveal d-Alanine:d-Alanine Ligase As the Target of d-Cycloserine in
    Prosser GA; de Carvalho LP
    ACS Med Chem Lett; 2013 Dec; 4(12):1233-1237. PubMed ID: 24478820
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of d-alanine on cycloserine blood levels in laboratory animals.
    Hawkins JE; McClean VR
    Am Rev Respir Dis; 1966 Apr; 93(4):617-8. PubMed ID: 5910683
    [No Abstract]   [Full Text] [Related]  

  • 68. [The activity of cycloserine on "paratubercular" mycobacteria].
    MORELLINI M; FERRARI S; FANTOLI U
    Ann Ist Carlo Forlanini; 1960; 20():68-85. PubMed ID: 13772514
    [No Abstract]   [Full Text] [Related]  

  • 69. [The action of cycloserine in experimental tuberculosis (Comparative studies between the histologic aspects and the level of concentration in the tissues)].
    BLASI A; PIAZZA R; ALIPERTA A; CATENA E
    Arch Tisiol Mal Appar Respir; 1959 Jul; 14():708-24. PubMed ID: 13801355
    [No Abstract]   [Full Text] [Related]  

  • 70. [Morphological analysis of the effect of cycloserine on experimental tuberculosis in white mice].
    MITROFANOV VS; RAZUMOVA IL
    Antibiotiki; 1960; 5():70-3. PubMed ID: 14423030
    [No Abstract]   [Full Text] [Related]  

  • 71. Reversal of cycloserine inhibition by D-alanine.
    SHOCKMAN GD
    Proc Soc Exp Biol Med; 1959; 101():693-5. PubMed ID: 14446135
    [No Abstract]   [Full Text] [Related]  

  • 72. Inhibition of the Synthesis of Wax D Peptidoglycolipid of Mycobacterium tuberculosis by d-Cycloserine.
    David HL; Goldman DS; Takayama K
    Infect Immun; 1970 Jan; 1(1):74-7. PubMed ID: 16557697
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Hydrolysis of diacetylcycloserine. In vitro and in vivo studies.
    Howard JC; McPherson JC; Chuang AH
    J Med Chem; 1974 Feb; 17(2):236-8. PubMed ID: 4809257
    [No Abstract]   [Full Text] [Related]  

  • 74. Recent Biochemical Advances in Antitubercular Drugs: Challenges and Future.
    Jain A; Kumar R; Mothsra P; Sharma AK; Singh AK; Kumar Y
    Curr Top Med Chem; 2024; 24(21):1829-1855. PubMed ID: 38919089
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Population Pharmacokinetics of Cycloserine and Pharmacokinetic/Pharmacodynamic Target Attainment in Multidrug-Resistant Tuberculosis Patients Dosed with Terizidone.
    Chirehwa MT; Court R; de Kock M; Wiesner L; de Vries N; Harding J; Gumbo T; Maartens G; Warren R; Denti P; McIlleron H
    Antimicrob Agents Chemother; 2020 Oct; 64(11):. PubMed ID: 32816738
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Novel Pharmacological Activity of Artesunate and Artemisinin: Their Potential as Anti-Tubercular Agents.
    Choi WH
    J Clin Med; 2017 Mar; 6(3):. PubMed ID: 28287416
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Tetrahydroisoquinolines affect the whole-cell phenotype of Mycobacterium tuberculosis by inhibiting the ATP-dependent MurE ligase.
    Guzman JD; Pesnot T; Barrera DA; Davies HM; McMahon E; Evangelopoulos D; Mortazavi PN; Munshi T; Maitra A; Lamming ED; Angell R; Gershater MC; Redmond JM; Needham D; Ward JM; Cuca LE; Hailes HC; Bhakta S
    J Antimicrob Chemother; 2015; 70(6):1691-703. PubMed ID: 25656411
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Structure and function of the transketolase from Mycobacterium tuberculosis and comparison with the human enzyme.
    Fullam E; Pojer F; Bergfors T; Jones TA; Cole ST
    Open Biol; 2012 Jan; 2(1):110026. PubMed ID: 22645655
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Structure of the Mycobacterium tuberculosis D-alanine:D-alanine ligase, a target of the antituberculosis drug D-cycloserine.
    Bruning JB; Murillo AC; Chacon O; Barletta RG; Sacchettini JC
    Antimicrob Agents Chemother; 2011 Jan; 55(1):291-301. PubMed ID: 20956591
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Galactosyl transferases in mycobacterial cell wall synthesis.
    Belánová M; Dianisková P; Brennan PJ; Completo GC; Rose NL; Lowary TL; Mikusová K
    J Bacteriol; 2008 Feb; 190(3):1141-5. PubMed ID: 18055597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.